Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Early animal and laboratory studies have explored its potential role in tissue repair and inflammation, but its cardiovascular effects and risks in humans remain unknown
Tight junction-related human diseases
We provide IV Mobile Therapy services
A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores
US$ 24.40
US$ 20.06
US$ 27.78
US$ 26.65
